| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Endonovo Therapeutics, Inc. (ENDV) has 0 insiders with recent SEC Form 4 filings, including 129 buys and 0 sells. ENDV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 25, 2019 | Collier Alan Brian | CEO | Buy | 700 | $0.01 | $4.57 | - | |
| Sep 11, 2019 | Collier Alan Brian | CEO | Buy | 32,000 | $0.01 | $288.20 | - | |
| Sep 5, 2019 | Collier Alan Brian | CEO | Buy | 114,000 | $0.01 | $1,113.20 | - | |
| Aug 29, 2019 | Collier Alan Brian | CEO | Buy | 119,000 | $0.01 | $1,225.80 | - | |
| Aug 19, 2019 | Collier Alan Brian | CEO | Buy | 55,000 | $0.01 | $597.00 | - | |
| Aug 13, 2019 | Collier Alan Brian | CEO | Buy | 89,500 | $0.01 | $917.60 | - | |
| Aug 7, 2019 | Collier Alan Brian | CEO | Buy | 62,000 | $0.01 | $698.40 | - | |
| Jul 24, 2019 | Collier Alan Brian | CEO | Buy | 96,000 | $0.01 | $1,185.70 | - | |
| Jul 11, 2019 | Collier Alan Brian | CEO | Buy | 59,700 | $0.02 | $921.34 | - | |
| Jul 8, 2019 | Collier Alan Brian | CEO | Buy | 275,000 | $0.02 | $4,436.60 | - |